ArticleJournal of ophthalmology2013

Bevacizumab for CRVO Associated CME: Effect of Timing and Frequency of Injections on Final Visual Outcome.

Joseph Pikkel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.